BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morroy G, Peters JB, van Nieuwenhof M, Bor HH, Hautvast JL, van der Hoek W, Wijkmans CJ, Vercoulen JH. The health status of Q-fever patients after long-term follow-up. BMC Infect Dis 2011;11:97. [PMID: 21501483 DOI: 10.1186/1471-2334-11-97] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ganter M. Zoonotic risks from small ruminants. Vet Microbiol 2015;181:53-65. [PMID: 26275853 DOI: 10.1016/j.vetmic.2015.07.015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
2 Strauss B, Löschau M, Seidel T, Stallmach A, Thomas A. Are fatigue symptoms and chronic fatigue syndrome following Q fever infection related to psychosocial variables? Journal of Psychosomatic Research 2012;72:300-4. [DOI: 10.1016/j.jpsychores.2012.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
3 van Loenhout JA, Paget WJ, Vercoulen JH, Wijkmans CJ, Hautvast JL, van der Velden K. Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date. BMC Infect Dis 2012;12:280. [PMID: 23110336 DOI: 10.1186/1471-2334-12-280] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
4 van Loenhout JA, van Tiel HH, van den Heuvel J, Vercoulen JH, Bor H, van der Velden K, Paget WJ, Hautvast JL. Serious long-term health consequences of Q-fever and Legionnaires' disease. Journal of Infection 2014;68:527-33. [DOI: 10.1016/j.jinf.2014.01.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
5 Keijmel SP, Delsing CE, Sprong T, Bleijenberg G, van der Meer JW, Knoop H, Bleeker-Rovers CP. The Qure study: Q fever fatigue syndrome--response to treatment; a randomized placebo-controlled trial. BMC Infect Dis 2013;13:157. [PMID: 23536997 DOI: 10.1186/1471-2334-13-157] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
6 van Loenhout JA, Paget WJ, Sandker GW, Hautvast JL, van der Velden K, Vercoulen JH. Assessing health status and quality of life of Q-fever patients: the Nijmegen Clinical Screening Instrument versus the Short Form 36. Health Qual Life Outcomes 2013;11:112. [PMID: 23826639 DOI: 10.1186/1477-7525-11-112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
7 Van Loenhout JA, Hautvast JL, Akkermans RP, Donders NC, Vercoulen JH, Paget WJ, van der Velden K. Work participation in Q-fever patients and patients with Legionnaires' disease: a 12-month cohort study. Scand J Public Health 2015;43:294-301. [PMID: 25724468 DOI: 10.1177/1403494815571030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
8 Hagenaars JC, Wever PC, Shamelian SO, Van Petersen AS, Hilbink M, Renders NH, De Jager-Leclercq GL, Moll FL, Koning OH. Vascular chronic Q fever: quality of life. Epidemiol Infect 2015;143:2903-9. [PMID: 25608699 DOI: 10.1017/S0950268814003951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Van Loenhout JAF, Wielders CCH, Morroy G, Cox MJM, Van Der Hoek W, Hautvast JLA, Paget WJ, Van Der Velden J. Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease. Epidemiol Infect 2015;143:2580-7. [DOI: 10.1017/s0950268814003689] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
10 Peters JB, Rijssenbeek-Nouwens LH, Bron AO, Fieten KB, Weersink EJ, Bel EH, Vercoulen JH. Health status measurement in patients with severe asthma. Respir Med 2014;108:278-86. [PMID: 24361162 DOI: 10.1016/j.rmed.2013.11.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
11 Melenotte C, Drancourt M, Gorvel JP, Mège JL, Raoult D. Post-bacterial infection chronic fatigue syndrome is not a latent infection. Médecine et Maladies Infectieuses 2019;49:140-9. [DOI: 10.1016/j.medmal.2019.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Kremers MN, Janssen R, Wielders CC, Kampschreur LM, Schneeberger PM, Netten PM, de Klerk A, Hodemaekers HM, Hermans MH, Notermans DW, Wever PC. Correlations between peripheral blood Coxiella burnetii DNA load, interleukin-6 levels, and C-reactive protein levels in patients with acute Q fever. Clin Vaccine Immunol 2014;21:484-7. [PMID: 24477856 DOI: 10.1128/CVI.00715-13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Keijmel SP, Krijger E, Delsing CE, Sprong T, Nabuurs-Franssen MH, Bleeker-Rovers CP. Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands. Emerg Infect Dis 2015;21:1348-56. [PMID: 26196955 DOI: 10.3201/eid2108.140196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
14 van der Hoek W, Morroy G, Renders NH, Wever PC, Hermans MH, Leenders AC, Schneeberger PM. Epidemic Q fever in humans in the Netherlands. Adv Exp Med Biol 2012;984:329-64. [PMID: 22711640 DOI: 10.1007/978-94-007-4315-1_17] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 7.0] [Reference Citation Analysis]
15 Teunis PF, Schimmer B, Notermans DW, Leenders AC, Wever PC, Kretzschmar ME, Schneeberger PM. Time-course of antibody responses against Coxiella burnetii following acute Q fever. Epidemiol Infect 2013;141:62-73. [PMID: 22475210 DOI: 10.1017/S0950268812000404] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
16 Oei W, Kretzschmar ME, Zaaijer HL, Coutinho R, van der Poel CL, Janssen MP. Estimating the transfusion transmission risk of Q fever: Transfusion Transmission Risk of Q Fever. Transfusion 2014;54:1705-11. [DOI: 10.1111/trf.12539] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
17 van Roeden SE, Reukers DFM, van Jaarsveld CHM, Kampschreur LM, Hoepelman IM, Wever PC, Bleeker-Rovers CP, Oosterheert JJ. Chronic Q fever: patient and treatment-related factors influencing long-term quality of life. QJM 2018;111:791-7. [PMID: 30102400 DOI: 10.1093/qjmed/hcy171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Morroy G, Bor HHJ, Polder J, Hautvast JLA, van der Hoek W, Schneeberger PM, Wijkmans CJ. Self-reported sick leave and long-term health symptoms of Q-fever patients. The European Journal of Public Health 2012;22:814-9. [DOI: 10.1093/eurpub/cks003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
19 Limonard GJM, Peters JB, Besselink R, Groot CAR, Dekhuijzen PNR, Vercoulen JH, Nabuurs-franssen MH. Persistence of impaired health status of Q fever patients 4 years after the first Dutch outbreak. Epidemiol Infect 2016;144:1142-7. [DOI: 10.1017/s0950268815002216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
20 Keijmel SP, Raijmakers RP, Bleeker-Rovers CP, van der Meer JW, Netea MG, Schoffelen T, van Deuren M. Altered interferon-γ response in patients with Q-fever fatigue syndrome. J Infect 2016;72:478-85. [PMID: 26820634 DOI: 10.1016/j.jinf.2016.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
21 Bruschke C, Roest H, Coutinho R. Q fever: the Dutch policy. Journal of Risk Research 2016;19:1022-35. [DOI: 10.1080/13669877.2015.1042498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
22 Morroy G, Keijmel SP, Delsing CE, Bleijenberg G, Langendam M, Timen A, Bleeker-Rovers CP. Fatigue following Acute Q-Fever: A Systematic Literature Review. PLoS One 2016;11:e0155884. [PMID: 27223465 DOI: 10.1371/journal.pone.0155884] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
23 Schneeberger PM, Wintenberger C, van der Hoek W, Stahl JP. Q fever in the Netherlands - 2007-2010: what we learned from the largest outbreak ever. Med Mal Infect 2014;44:339-53. [PMID: 25108615 DOI: 10.1016/j.medmal.2014.02.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 7.4] [Reference Citation Analysis]
24 Baliatsas C, Dückers M, Smit L, Heederik D, Yzermans J. Morbidity Rates in an Area with High Livestock Density: A Registry-Based Study Including Different Groups of Patients with Respiratory Health Problems. Int J Environ Res Public Health 2020;17:E1591. [PMID: 32121551 DOI: 10.3390/ijerph17051591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Morroy G, Van Der Hoek W, Nanver ZD, Schneeberger PM, Bleeker-Rovers CP, Van Der Velden J, Coutinho RA. The health status of a village population, 7 years after a major Q fever outbreak. Epidemiol Infect 2016;144:1153-62. [PMID: 26560803 DOI: 10.1017/S0950268815002472] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
26 Brooke RJ, Van Lier A, Donker GA, Van Der Hoek W, Kretzschmar MEE. Comparing the impact of two concurrent infectious disease outbreaks on The Netherlands population, 2009, using disability-adjusted life years. Epidemiol Infect 2014;142:2412-21. [DOI: 10.1017/s0950268813003531] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Keijmel SP, Saxe J, van der Meer JW, Nikolaus S, Netea MG, Bleijenberg G, Bleeker-Rovers CP, Knoop H. A comparison of patients with Q fever fatigue syndrome and patients with chronic fatigue syndrome with a focus on inflammatory markers and possible fatigue perpetuating cognitions and behaviour. J Psychosom Res 2015;79:295-302. [PMID: 26272528 DOI: 10.1016/j.jpsychores.2015.07.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
28 van Loenhout JA, Hautvast JL, Vercoulen JH, Akkermans RP, Wijkmans CJ, van der Velden K, Paget WJ. Q-fever patients suffer from impaired health status long after the acute phase of the illness: Results from a 24-month cohort study. Journal of Infection 2015;70:237-46. [DOI: 10.1016/j.jinf.2014.10.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
29 Hopper B, Cameron B, Li H, Graves S, Stenos J, Hickie I, Wakefield D, Vollmer-conna U, Lloyd A. The natural history of acute Q fever: a prospective Australian cohort. QJM 2016;109:661-8. [DOI: 10.1093/qjmed/hcw041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Robison A, Snyder DT, Christensen K, Kimmel E, Hajjar AM, Jutila MA, Hedges JF. Expression of human TLR4/myeloid differentiation factor 2 directs an early innate immune response associated with modest increases in bacterial burden during Coxiella burnetii infection. Innate Immun 2019;25:401-11. [PMID: 31180798 DOI: 10.1177/1753425919855420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Roest HI, Bossers A, van Zijderveld FG, Rebel JM. Clinical microbiology of Coxiella burnetii and relevant aspects for the diagnosis and control of the zoonotic disease Q fever. Vet Q 2013;33:148-60. [PMID: 24161079 DOI: 10.1080/01652176.2013.843809] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
32 Mørch K, Hanevik K, Rivenes AC, Bødtker JE, Næss H, Stubhaug B, Wensaas KA, Rortveit G, Eide GE, Hausken T, Langeland N. Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. BMC Gastroenterol 2013;13:28. [PMID: 23399438 DOI: 10.1186/1471-230X-13-28] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
33 Gidding HF, Graves SR. Could it be Q fever? Medical Journal of Australia 2013;198:9-10. [DOI: 10.5694/mja12.11461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Hanevik K, Wensaas KA, Rortveit G, Eide GE, Mørch K, Langeland N. Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study. Clin Infect Dis 2014;59:1394-400. [PMID: 25115874 DOI: 10.1093/cid/ciu629] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 9.8] [Reference Citation Analysis]
35 Klous G, Smit LAM, Freidl GS, Borlée F, van der Hoek W, IJzermans CJ, Kretzschmar MEE, Heederik DJJ, Coutinho RA, Huss A. Pneumonia risk of people living close to goat and poultry farms - Taking GPS derived mobility patterns into account. Environ Int 2018;115:150-60. [PMID: 29573654 DOI: 10.1016/j.envint.2018.03.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Smit LA, van der Sman-de Beer F, Opstal-van Winden AW, Hooiveld M, Beekhuizen J, Wouters IM, Yzermans J, Heederik D. Q fever and pneumonia in an area with a high livestock density: a large population-based study. PLoS One 2012;7:e38843. [PMID: 22685612 DOI: 10.1371/journal.pone.0038843] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
37 van Dam AS, van Loenhout JA, Peters JB, Rietveld A, Paget WJ, Akkermans RP, Olde Loohuis A, Hautvast JL, van der Velden J. A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections, including Q fever. Epidemiol Infect 2015;143:48-54. [PMID: 24625631 DOI: 10.1017/S0950268814000417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]